Robert Torray - Torray Investment Partners
Holding/activity history for BioMarin Pharmaceutical Inc. (BMRN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 78,170 | 0.69 | Buy | 0.69 | $56.49 | $4,415,823 | SEC |
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | 0.21 | SEC | ||
| 2024 Q2 | 16,855 | 0.21 | Add 13.61% | 0.03 | $82.33 | $1,387,672 | SEC |
| 2024 Q1 | 14,836 | 0.19 | Add 1.15% | <0.01 | $87.34 | $1,295,776 | SEC |
| 2023 Q4 | 14,668 | 0.23 | Add 3.14% | <0.01 | $96.42 | $1,414,289 | SEC |
| 2023 Q3 | 14,222 | 0.22 | Add 29.51% | 0.05 | $88.48 | $1,258,363 | SEC |
| 2023 Q2 | 10,981 | 0.16 | Add 0.96% | <0.01 | $86.68 | $951,833 | SEC |
| 2023 Q1 | 10,877 | 0.19 | Add 0.40% | <0.01 | $97.24 | $1,057,679 | SEC |
| 2022 Q4 | 10,834 | 0.20 | Reduce 4.12% | <0.01 | $103.49 | $1,121,211 | SEC |
| 2022 Q3 | 11,300 | 0.19 | Reduce 2.33% | <0.01 | $84.78 | $958,000 | SEC |
| 2022 Q2 | 11,569 | 0.18 | Reduce 0.16% | <0.01 | $82.89 | $959,000 | SEC |
| 2022 Q1 | 11,587 | 0.14 | Reduce 5.31% | <0.01 | $77.07 | $893,000 | SEC |
| 2021 Q4 | 12,237 | 0.16 | Reduce 25.40% | 0.05 | $88.34 | $1,081,000 | SEC |
| 2021 Q3 | 16,403 | 0.19 | Add 1.26% | <0.01 | $77.30 | $1,268,000 | SEC |
| 2021 Q2 | 16,199 | 0.20 | Add 0.88% | <0.01 | $83.46 | $1,352,000 | SEC |
| 2021 Q1 | 16,057 | 0.19 | Reduce 75.72% | 0.73 | $75.48 | $1,212,000 | SEC |
| 2020 Q4 | 66,127 | 0.96 | Reduce 3.31% | 0.03 | $87.69 | $5,799,000 | SEC |
| 2020 Q3 | 68,390 | 0.96 | Add 26.48% | 0.20 | $76.08 | $5,203,000 | SEC |
| 2020 Q2 | 54,070 | 1.26 | Reduce 10.69% | 0.12 | $123.34 | $6,669,000 | SEC |
| 2020 Q1 | 60,542 | 1.13 | Add 7.14% | 0.08 | $84.50 | $5,116,000 | SEC |
| 2019 Q4 | 56,505 | 0.82 | Reduce 72.02% | 1.07 | $84.54 | $4,777,000 | SEC |
| 2019 Q3 | 201,955 | 1.48 | Add 0.47% | <0.01 | $67.40 | $13,612,000 | SEC |
| 2019 Q2 | 201,001 | 1.79 | Reduce 8.67% | 0.18 | $85.65 | $17,216,000 | SEC |
| 2019 Q1 | 220,087 | 2.08 | Reduce 2.03% | 0.05 | $88.83 | $19,550,000 | SEC |
| 2018 Q4 | 224,639 | 2.30 | Reduce 5.32% | 0.12 | $85.15 | $19,128,000 | SEC |
| 2018 Q3 | 237,271 | 2.32 | Reduce 1.83% | 0.04 | $96.97 | $23,008,000 | SEC |
| 2018 Q2 | 241,695 | 2.41 | Reduce 3.32% | 0.07 | $94.20 | $22,768,000 | SEC |
| 2018 Q1 | 249,996 | 2.13 | Add 0.89% | 0.02 | $81.07 | $20,267,000 | SEC |
| 2017 Q4 | 247,799 | 2.21 | Add 8.31% | 0.17 | $89.17 | $22,096,000 | SEC |
| 2017 Q3 | 228,796 | 2.13 | Add 0.63% | 0.01 | $93.07 | $21,294,000 | SEC |
| 2017 Q2 | 227,360 | 2.17 | Reduce 7.76% | 0.18 | $90.82 | $20,649,000 | SEC |
| 2017 Q1 | 246,485 | 2.27 | Reduce 1.58% | 0.03 | $87.78 | $21,636,000 | SEC |
| 2016 Q4 | 250,438 | 2.21 | Add 28.50% | 0.49 | $82.84 | $20,746,000 | SEC |
| 2016 Q3 | 194,892 | 1.98 | Reduce 46.48% | 1.00 | $92.52 | $18,031,000 | SEC |
| 2016 Q2 | 364,180 | 2.15 | Reduce 18.71% | 0.36 | $77.80 | $28,333,000 | SEC |
| 2016 Q1 | 448,000 | 1.93 | Add 94.81% | 0.94 | $82.48 | $36,951,000 | SEC |
| 2015 Q4 | 229,965 | 1.79 | Add 0.93% | 0.02 | $104.76 | $24,091,000 | SEC |
| 2015 Q3 | 227,845 | 1.76 | Reduce 1.02% | 0.02 | $105.32 | $23,997,000 | SEC |
| 2015 Q2 | 230,195 | 2.05 | Reduce 10.24% | 0.38 | $136.78 | $31,486,000 | SEC |
| 2015 Q1 | 256,455 | 3.74 | Reduce 15.79% | 0.37 | $124.62 | $31,959,000 | SEC |
| 2014 Q4 | 304,560 | 2.34 | Reduce 13.20% | 0.31 | $90.40 | $27,532,000 | SEC |
| 2014 Q3 | 350,895 | 2.35 | Add 27.51% | 0.51 | $72.16 | $25,321,000 | SEC |
| 2014 Q2 | 275,185 | 1.78 | Add 324.64% | 1.36 | $62.21 | $17,119,000 | SEC |
| 2014 Q1 | 64,805 | 0.78 | Buy | 0.78 | $68.20 | $4,420,000 | SEC |